Oxford StemTech

Oxford StemTech is a contract research company providing induced pluripotent stem cell (iPSC) reprogramming and drug discovery services using its proprietary platform.

The technology enables large-scale, cost-effective generation of patient-derived iPSC lines from blood or skin samples, supporting disease modelling, drug target discovery, and compound screening.

Services include differentiation into disease-relevant cell types and cell-based assays for neurological and other complex conditions.

The company also distributes iPSC lines under agreement with the University of Oxford.